Table V.
Category | Term | Count | P-value |
---|---|---|---|
GO biology process | GO:0001568~blood vessel development | 16 | 4.26×10−7a |
GO:0001944~vasculature development | 16 | 5.81×10−7a | |
GO:0001525~angiogenesis | 10 | 9.95×10−5a | |
GO:0007155~cell adhesion | 22 | 1.72×10−4a | |
GO:0022610~biological adhesion | 22 | 1.75×10−4a | |
GO:0048514~blood vessel morphogenesis | 11 | 3.19×10−4a | |
GO:0006928~cell motion | 14 | 6.66×10−3a | |
GO:0051674~localization of cell | 10 | 1.51×10−2a | |
GO:0048870~cell motility | 10 | 1.51×10−2a | |
GO:0008219~cell death | 16 | 3.56×10−2a | |
GO:0016265~death | 16 | 3.75×10−2a | |
GO:0006915~apoptosis | 14 | 3.87×10−2a | |
GO:0012501~programmed cell death | 14 | 4.27×10−2a | |
GO cellular component | GO:0031012~extracellular matrix | 14 | 3.11×10−4a |
GO:0005578~proteinaceous extracellular matrix | 12 | 1.89×10−3a | |
GO:0009986~cell surface | 11 | 1.03×10−2a | |
GO:0044421~extracellular region part | 20 | 2.47×10−2a | |
GO:0005794~golgi apparatus | 18 | 3.72×10−2a | |
GO molecular function | GO:0030246~carbohydrate binding | 13 | 1.10×10−3a |
GO:0005198~structural molecule activity | 17 | 3.75×10−3a | |
GO:0032555~purine ribonucleotide binding | 32 | 2.72×10−2a | |
GO:0032553~ribonucleotide binding | 32 | 2.72×10−2a | |
GO:0017076~purine nucleotide binding | 33 | 2.89×10−2a | |
GO:0001882~nucleoside binding | 28 | 4.24×10−2a | |
GO:0005524~ATP binding | 26 | 4.52×10−2a | |
Pathway | hsa04512:ECM-receptor interaction | 8 | 6.16×10−6a |
hsa04510:Focal adhesion | 10 | 6.47×10−5a | |
hsa04810:regulation of actin cytoskeleton | 7 | 4.57×10−3a | |
hsa03010:ribosome | 4 | 8.91×10−3a | |
hsa04350:TGF-beta signaling pathway | 3 | 2.87×10−2a | |
hsa04142:lysosome | 3 | 4.20×10−2a |
Significant P-value.